TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation

被引:96
|
作者
Doedens, JR [1 ]
Mahimkar, RM [1 ]
Black, RA [1 ]
机构
[1] Amgen Inc, Dept Cell Biol, Seattle, WA 98101 USA
关键词
ectodomain shedding; metalloprotease; disintegrin; TACE; ADAM; TNF;
D O I
10.1016/S0006-291X(03)01381-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor-alpha converting enzyme (TACE/ADAM-17) is a metalloprotease disintegrin that cleaves a variety of membrane proteins, releasing ("shedding") their extracellular domains from cells. Most TACE-mediated shedding events occur at low basal rates that are enhanced by treatment of cells with a variety of stimuli. To study the mechanism of induced shedding, we developed a peptide-cleavage assay that measures the cellular TACE activity. In unstimulated cells, cleavage of a TNFalpha processing-site peptide was mediated mainly by enzymes other than TACE. However, stimulation of cells with phorbol-12-myristate-13-acetate (PMA) increased peptide cleavage in a TACE-dependent manner. PMA treatment did not increase the amount of TACE on the cell surface. Moreover, the cytoplasmic domain of TACE was not required for the induced activity. Based on these observations, induction of TACE-mediated shedding events occurs at least in part via an increase in the enzymatic activity of cellular TACE, independent of its cytoplasmic domain. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 50 条
  • [1] TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity
    Srour, N
    Lebel, A
    McMahon, S
    Fournier, I
    Fugère, M
    Day, R
    Dubois, CM
    FEBS LETTERS, 2003, 554 (03) : 275 - 283
  • [2] Induced activation of cell-surface TACE/ADAM-17
    Doedens, JR
    Black, RA
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 199A - 199A
  • [3] FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity
    Canault, Matthias
    Tellier, Edwige
    Bonardo, Bernadette
    Mas, Eric
    Aumailley, Monique
    Juhan-Vague, Irene
    Nalbone, Gilles
    Peiretti, Franck
    JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 208 (02) : 363 - 372
  • [4] Microparticles isolated from human atherosclerotic plaques contain active TACE/ADAM-17
    Canault, M
    Leroyer, A
    Peiretti, F
    Lesèche, G
    Tedgui, A
    Juhan-Vague, I
    Boulanger, CM
    Nalbone, G
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E50 - E50
  • [5] INCREASED ADAM-17 ACTIVITY IN NEUTROPHILS FROM PATIENTS WITH CYSTIC FIBROSIS IS CORRECTED BY POTENTIATOR THERAPY
    White, M.
    Flannery, R.
    Hawkins, P.
    McElvaney, N. G.
    Reeves, E.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 234 - 234
  • [6] Serotonin-induced ERK phosphorylation involves ADAM-17/TACE activation in mesangial cells
    Gooz, M
    Gooz, P
    Raymond, JR
    FEBS JOURNAL, 2005, 272 : 180 - 180
  • [7] ADAM-17 Concentration Is Increased in Severe Alpha-1-Antitrypsin Deficiency
    Leacy, E.
    Proceviat, D.
    Alhaddah, L.
    Sharma, A.
    He, Y.
    Annie, C. M.
    Murphy, M. P.
    Herron, M.
    Mcelvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [8] Association of c-Src and TACE/ADAM-17 Induce Amphiregulin-Dependent EGFR Signaling
    Nagathihalli, N. S.
    Washington, M. K.
    Coffey, R.
    Merchant, N. B.
    PANCREAS, 2011, 40 (08) : 1342 - 1343
  • [9] TACE/ADAM-17: A component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer
    Merchant, Nipun B.
    Voskresensky, Igor
    Rogers, Christopher M.
    LaFleur, Bonnie
    Dempsey, Peter J.
    Graves-Deal, Ramona
    Revetta, Frank
    Foutch, A. Coe
    Rothenberg, Mace L.
    Washington, Mary K.
    Coffey, Robert J.
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1182 - 1191
  • [10] ADAM17/TACE is a novel target of the unfolded protein response
    Petry, A.
    Rzymski, T.
    Kracun, D.
    Riess, F.
    Pike, L.
    Harris, A. L.
    Gorlach, A.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S95 - S95